Mantle cell lymphoma relapsed after autologous stem cell transplantation: a single-center experience.

Conclusion: Our findings suggest that ibrutinib can achieve relatively prolonged control of MCL progressing after autoSCT. PMID: 32269976 [PubMed]
Source: Blood Research - Category: Hematology Tags: Blood Res Source Type: research